Similar articles

• Re: Gender disparity in cardiac procedures and medication use for acute myocardial infarction.

  Ramaraj R. Ramaraj R. Am Heart J. 2008 Oct;156(4):e41; author reply e43. doi: 10.1016/j.ahj.2008.07.002. Epub 2008 Sep 9. Am Heart J. 2008. PMID: 18926142 No abstract available.
• The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.

  Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. Cambou JP, et al. Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):524-34. Arch Mal Coeur Vaiss. 2007. PMID: 17893635 Clinical Trial.
• Critical pathways for acute myocardial infarction.

  Cannon CP. Cannon CP. Rev Cardiovasc Med. 2003;4 Suppl 3:S47-53. Rev Cardiovasc Med. 2003. PMID: 14564234 Review.
• Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.

  Second Chinese Cardiac Study (CCS-2) Collaborative Group. Second Chinese Cardiac Study (CCS-2) Collaborative Group. J Cardiovasc Risk. 2000 Dec;7(6):435-41. J Cardiovasc Risk. 2000. PMID: 11189013 Clinical Trial.
• [Perspectives of the preventive treatment of patients after myocardial infarction].

  Chodorowski Z. Chodorowski Z. Pol Tyg Lek. 1984 Jan 30;39(5):159-61. Pol Tyg Lek. 1984. PMID: 6146127 Review. Polish. No abstract available.